# BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
> **NDA208374** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2017-12-21
## Drug
- **FDA Application Number:** NDA208374
- **Application type:** New Drug Application
- **Brand name:** BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
- **Generic name:** Bivalirudin
- **Active ingredients:** BIVALIRUDIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAXTER HLTHCARE CORP
- **First approval:** 2017-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208374)
---
*MORVS · CC0 1.0*